Soligenix Inc (NASDAQ:SNGX)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - SNGX

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - SNGX

  • Market Cap$54.320m
  • SymbolNASDAQ:SNGX
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS8342233074

Company Profile

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).Soligenix Inc focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need.

Latest SNGX news

Currently there for this company. Visit our news hub for other news .